Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Harvard University
- Nanyang Technological University
- University of Sydney
- King's College London
- National University of Singapore
- University of Birmingham
- Indiana University
- Monash University
- University of British Columbia
- University of Maryland, Baltimore
- University of Michigan
- Trinity College Dublin
- University of Oslo
- Zintellect
- City of Hope
- Northeastern University
- SINGAPORE INSTITUTE OF TECHNOLOGY (SIT)
- TAIPEI MEDICAL UNIVERSITY (TMU)
- University of Beira Interior
- University of Birmingham;
- University of California, Los Angeles
- University of Kansas Medical Center
- Carnegie Mellon University
- Cedars Sinai Medical Center
- Cellular and Molecular Therapeutics Branch, NHLBI, NIH
- Center for Biologics Evaluation and Research (CBER)
- Cold Spring Harbor Laboratory
- Georgetown University
- Macquarie University
- Nottingham Trent University
- QUEENS UNIVERSITY BELFAST
- Queen's University Belfast
- Shenzhen Bay Laboratory
- The University of Edinburgh;
- The University of Tokyo
- UCL;
- UNIVERSITY OF HELSINKI
- UNIVERSITY OF SURREY
- UNIVERSITY OF SYDNEY
- University College London
- University of Canterbury
- University of Denver
- University of Gloucestershire;
- University of Hull;
- University of Maryland School of Medicine, Baltimore
- University of North Carolina at Chapel Hill
- University of Oxford
- University of Sheffield
- University of Tennessee Medical Center at Knoxville
- University of Texas Rio Grande Valley
- University of Texas at Austin
- Virginia Tech
- Yeshiva University
- eQuest
- Łukasiewicz PORT
- 45 more »
- « less
-
Field
-
program focused on obesity and eating disorders, with a particular emphasis on developing and evaluating screening and assessment pathways to improve health outcomes for children, adolescents, and families
-
research project focused on mechanistic dissection of a neurodevelopmental genetic disorder and preclinical development of antisense oligonucleotide (ASO) therapeutics. The successful candidate will lead and
-
disorders, many of whom have limited or no treatments available. This unit is based in Boston, Massachusetts, with a strong synergy with the headquarters in Parma. The GRD unit has a focus on research and
-
The Signature Research Programme in Neuroscience and Behavioural Disorders (NBD) is focused on understanding the structure and function of the nervous system, and the neural mechanisms underlying
-
at national facilities to reveal short-range correlated disorder, invisible to long-range structure probes. This project will use a state-of-the-art, laser-heated, high-pressure image furnace to synthesise
-
and description of the project] * Background of the recruitment and description of the project At IRCN, we focus on brain development and its disorders to inspire novel AI, as well as their application
-
development and human diseases, such as neurological disorder, immunology, and cancer. Utilize biochemistry, molecular biology, CRISPR-based genomic screen, single-cell transcriptomics, and genetically modified
-
postdoctoral research fellow for projects related to comparative effectiveness and safety of interventions in mental health (early psychosis, suicide prevention, opioid use disorder). The candidate will be
-
that explore biological and behavioural factors influencing the onset, course, and response to treatment in young people with emerging mental disorders. Extensive collaborations with clinicians, data scientists
-
in neurodegenerative and neuromuscular disorders. The researcher will be based at the Institute of Biotechnology, University of Helsinki. The Institute provides state-of-the-art research